Institutional Ownership
Aptevo Therapeutics Inc
CUSIP 03835L702COM SHS NEWAPVOQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
8.2%
Max % of class reported
Institutional Holders
7
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Cvi Investments, Inc. | 13G/A | 8.2% | 83.9K | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Geode Capital Management, LLC | 13.3K | $56.9K |
| 2 | Ubs Group AG | 3.4K | $14.7K |
| 3 | Osaic Holdings, Inc. | 360 | $1.5K |
| 4 | Sbi Securities Co., Ltd. | 109 | $465 |
| 5 | Gsa Capital Partners LLP | 19.6K | $84 |
| 6 | Cwm, LLC | 5 | $21 |
| 7 | Danske Bank A/S | 1 | $4 |